Camille L Bedrosian - Net Worth and Insider Trading
Camille L Bedrosian Net Worth
The estimated net worth of Camille L Bedrosian is at least $3 Million dollars as of 2024-11-13. Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc and owns about 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) stock worth over $2 Million. Camille L Bedrosian is also the Chief Medical Officer of Amylyx Pharmaceuticals Inc and owns about 143,801 shares of Amylyx Pharmaceuticals Inc (AMLX) stock worth over $896,599. Details can be seen in Camille L Bedrosian's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Camille L Bedrosian has not made any transactions after 2024-09-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Camille L Bedrosian
Camille L Bedrosian Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Camille L Bedrosian owns 4 companies in total, including Ultragenyx Pharmaceutical Inc (RARE) , Crinetics Pharmaceuticals Inc (CRNX) , and ARIAD Pharmaceuticals Inc (ARIA) among others .
Click here to see the complete history of Camille L Bedrosian’s form 4 insider trades.
Insider Ownership Summary of Camille L Bedrosian
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | EVP and Chief Medical Officer |
| CRNX | Crinetics Pharmaceuticals Inc | 2020-09-01 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2007-04-16 | VP & Chief Medical Officer |
 | | 2020-12-09 | director |
Camille L Bedrosian Latest Holdings Summary
Camille L Bedrosian currently owns a total of 2 stocks. Among these stocks, Camille L Bedrosian owns 46,720 shares of Ultragenyx Pharmaceutical Inc (RARE) as of March 1, 2023, with a value of $2 Million and a weighting of 71.35%. Camille L Bedrosian also owns 143,801 shares of Amylyx Pharmaceuticals Inc (AMLX) as of September 30, 2024, with a value of $896,599 and a weighting of 28.65%.
Latest Holdings of Camille L Bedrosian
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RARE | Ultragenyx Pharmaceutical Inc | 2023-03-01 | 46,720 | 47.79 | 2,232,749 |
| AMLX | Amylyx Pharmaceuticals Inc | 2024-09-30 | 143,801 | 6.24 | 896,599 |
Holding Weightings of Camille L Bedrosian
Camille L Bedrosian Form 4 Trading Tracker
According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 11 transactions in Ultragenyx Pharmaceutical Inc (RARE) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Ultragenyx Pharmaceutical Inc is the sale of 3,881 shares on March 1, 2023, which brought Camille L Bedrosian around $175,615.
According to the SEC Form 4 filings, Camille L Bedrosian has made a total of 1 transactions in Amylyx Pharmaceuticals Inc (AMLX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Amylyx Pharmaceuticals Inc is the sale of 11,442 shares on September 30, 2024, which brought Camille L Bedrosian around $36,614.
Insider Trading History of Camille L Bedrosian
- 1
Camille L Bedrosian Trading Performance
Camille L Bedrosian Ownership Network
Ownership Network List of Camille L Bedrosian
Ownership Network Relation of Camille L Bedrosian
Camille L Bedrosian Owned Company Details
What does Ultragenyx Pharmaceutical Inc do?
Who are the key executives at Ultragenyx Pharmaceutical Inc?
Camille L Bedrosian is the EVP and Chief Medical Officer of Ultragenyx Pharmaceutical Inc. Other key executives at Ultragenyx Pharmaceutical Inc include Chief Financial Officer Howard Horn , director & 10 percent owner & President & CEO Emil D Kakkis , and Controller and PAO Theodore Alan Huizenga .
Ultragenyx Pharmaceutical Inc (RARE) Insider Trades Summary
Over the past 18 months, Camille L Bedrosian made no insider transaction in Ultragenyx Pharmaceutical Inc (RARE). Other recent insider transactions involving Ultragenyx Pharmaceutical Inc (RARE) include a net sale of 147,853 shares made by Emil D Kakkis , a net sale of 4,391 shares made by Sanders Corazon (corsee) D. , and a net sale of 3,565 shares made by Theodore Alan Huizenga .
In summary, during the past 3 months, insiders sold 27,556 shares of Ultragenyx Pharmaceutical Inc (RARE) in total and bought 0 shares, with a net sale of 27,556 shares. During the past 18 months, 260,421 shares of Ultragenyx Pharmaceutical Inc (RARE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 260,421 shares.
Ultragenyx Pharmaceutical Inc (RARE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Ultragenyx Pharmaceutical Inc Insider Transactions
Camille L Bedrosian Mailing Address
Above is the net worth, insider trading, and ownership report for Camille L Bedrosian. You might contact Camille L Bedrosian via mailing address: C/o Ultragenyx Pharmaceutical Inc., 60 Leveroni Court, Novato Ca 94949.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
